Drug Repurposing Reveals mTOR Inhibition as a Promising Strategy for Epidermolysis Bullosa Simplex. Ragot H, Hovnanian A. J Invest Dermatol 2022;142:275-278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ragot H, Hovnanian A. Drug Repurposing Reveals mTOR Inhibition as a Promising Strategy for Epidermolysis Bullosa Simplex. J Invest Dermatol 2022;142:275-278.
PMID: 34924185